Lung cancer, which causes more deaths worldwide than any other malignancy, is revealing its vulnerabilities under a sustained assault from science. Many of the most recent advances against the disease have a long pedigree at Dana-Farber. It was 10 years ago, in fact, that Dana-Farber scientists and elsewhere showed non-small cell lung cancers that carry … Read more
Ten years ago researchers at Dana-Farber and in Japan published a study showing that lung cancer patients whose tumors had a malfunctioning version of a protein called Epidermal Growth Factor Receptor (EGFR) responded dramatically to a drug that specifically targets the EGFR protein. The findings launched the era of precision medicine for lung cancer, transforming … Read more
Experts with the U.S. Preventive Services Task Force (USPSTF) have recommended that current smokers and former-smokers who recently quit should undergo an annual low-dose CT scan to screen for lung cancer.
Despite the research, the promising new drugs, the many ongoing clinical trials, lung cancer remains a disease that affects too many people, too often. For patients and family members, the disease carries an added burden: a stigma that lung cancer and smoking go hand in hand, and that lung cancer patients brought this on themselves. … Read more
Medically reviewed by Pasi A. Jänne, MD, PhD Lung cancer develops in the tissue of the lung, usually in the cells that line the air passages. Here are some common questions about the disease, answered by Pasi A. Jänne, MD, PhD, Director of Dana-Farber’s Lowe Center for Thoracic Oncology. What are the types of lung cancer? There are … Read more
Lung cancer can be a frightening diagnosis. However, new treatment approaches and promising research trends have made the outlook for patients a little more optimistic, says David Jackman, MD, an oncologist in the Lowe Center for Thoracic Oncology at Dana-Farber Cancer Institute.
While other kinds of cancer may receive more public attention, lung cancer remains the leading cause of cancer deaths. There are two main types of lung cancer: small cell carcinoma and non-small cell carcinoma, both of which mainly affect people over 45 years old. We spoke with Bruce E. Johnson, MD about causes and treatment options.
Cold plunges, the act of immersing the body in cold water for therapeutic benefit, have been used for centuries — from vinterbading in Scandinavia (swimming in cold water during winter months) to misogi in Japan (a Shinto practice of purifying the body under a cold or icy waterfall) to ice baths in the United States … Read more
The growing excitement about the potential of immunotherapy treatments for cancer continued at the 2015 meeting of the American Association for Cancer Research (AACR), one of the largest cancer research meetings of the year. Several Dana-Farber investigators presented encouraging results of immunotherapy for melanoma, lung cancer, and breast cancer. F. Stephen Hodi, MD, and Leena … Read more
The differences between cancers in adults and children go well beyond age. In many respects, they are markedly different diseases.
As we close out the first quarter of the twenty-first century, it isn’t hard to notice how much the world has changed since the year 2000. Smartphones. Social media. Artificial intelligence. But how much has cancer care changed? A lot. Possibly more than you think. Treatment for many cancers now include many options beyond chemotherapy, … Read more
Whether it may be genetic or environmental, there are many factors that can lead to cancer. One of these factors could be infections, which can be caused by bacteria, fungi, and/or viruses. Viruses insert themselves inside our bodies and alter our otherwise functioning genes, making us sick. Viruses can only thrive when they infect a … Read more
Cancer can make its way through the body by shapeshifting through even the narrowest places, like a skilled driver navigating traffic. It has a sly way of adapting to its environment by finding detours around every blockade clinicians place in its path. A study from the lab of Nilay Sethi, MD, PhD, in Dana-Farber’s Center … Read more
When Donna McDaniel came to Dana-Farber with what she thought was lung cancer in 2024, she could barely walk and struggled to breathe. She’d been treated elsewhere, but the drugs had seemingly stopped working. Her quality of life was suffering, and she couldn’t keep up with her busy catering job at Blue Cross Blue Shield. … Read more
What is TIL (tumor-infiltrating lymphocyte) therapy? Tumor-infiltrating lymphocyte, or TIL, therapy uses a patient’s own immune system T cells to fight cancer. The therapy involves removing T cells from a piece of the patient’s tumor – where the T cells have congregated after being alerted to the cancer – growing them outside the body, then … Read more
Immunotherapy drugs can be more effective against cancer when combined with other therapies, such as radiation therapy, targeted drugs, immunotherapy agents, and with chemotherapy. What is chemotherapy? Chemotherapy drugs have been used for decades to treat cancer, either alone or in combination therapies. These drugs kill rapidly dividing cells, including tumor cells, using a variety of mechanisms. … Read more
The American Cancer Society 2025 Facts and Figures report contained alarming information about cancer rates in young women. Women under 50 are getting cancer more frequently than men of the same age. In 2022, for every young man who got cancer, about 1.5 young women did. Now that number is closer to 1.8. The cause … Read more
In recent decades, rates of some cancers, such as colorectal cancer, have been rising in young adults under the age of 50. One possible explanation for this rise is a parallel rise in obesity rates and changes in diet, activity levels and lifestyle. However, says Kimmie Ng, MD, MPH, director of Dana-Farber’s Young-Onset Colorectal Cancer … Read more
A blood test can now detect the presence of 50 different cancers — most of which do not have any other means of screening. The test, the GRAIL Galleri multi-cancer early detection (MCED) test, reports results that include a yes or no readout regarding the presence of a potential cancer, plus the most likely location … Read more
Respiratory syncytial virus, or RSV, is a common respiratory virus. RSV symptoms are similar to the common cold – congestion, runny nose, fever, and sore throat. RSV infection is usually mild, but it can be severe for infants, older adults, and individuals with immunocompromising conditions, including cancer. In infants, it can lead to pneumonia or … Read more